Effect of Opicapone at Steady State on Warfarin Pharmacokinetics
NCT02305030 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2014-12-02
Summary
Single-centre, open-label, fixed-sequence design consisting of 2 periods separated by a washout period of at least 14 days.
Conditions
Interventions
- DRUG
-
BIA 9-1067
- DRUG
-
Warfarin
Sponsors & Collaborators
-
Bial - Portela C S.A.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
More Related Trials
-
Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
NCT01359462 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin
NCT06207682 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
NCT02225626 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
NCT03500627 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
NCT02116465 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers
NCT03072056 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production
NCT03551769 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects
NCT03095105 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Pharmacokinetic Study of Aprepitant Injection in Humans
NCT06226506 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
NCT01933503 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Transporter Interaction Study PHENTRA_2015_KPUK
NCT02743260 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers
NCT03866928 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants
NCT06973005 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment
NCT00768209 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Bosentan on the Pharmacokinetics of Nintedanib
NCT02667704 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production
NCT03971123 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
NCT07166783 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Two Oral Bemiparin Formulations
NCT00863577 ·Status: COMPLETED ·Phase: PHASE1
-
STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT
NCT04604496 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196
NCT04867941 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Explore Pharmacokinetics and Pharmacodynamics of a Single Rising Dose of BI 135585 XX
NCT01652742 ·Status: COMPLETED ·Phase: PHASE1
-
A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
NCT02009878 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
NCT01767103 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809
NCT02362516 ·Status: COMPLETED ·Phase: PHASE1